Correlation Between Spire Global and Relief Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spire Global and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spire Global and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spire Global and Relief Therapeutics Holding, you can compare the effects of market volatilities on Spire Global and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spire Global with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spire Global and Relief Therapeutics.

Diversification Opportunities for Spire Global and Relief Therapeutics

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Spire and Relief is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Spire Global and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and Spire Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spire Global are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of Spire Global i.e., Spire Global and Relief Therapeutics go up and down completely randomly.

Pair Corralation between Spire Global and Relief Therapeutics

Given the investment horizon of 90 days Spire Global is expected to generate 79.95 times less return on investment than Relief Therapeutics. But when comparing it to its historical volatility, Spire Global is 26.71 times less risky than Relief Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Relief Therapeutics Holding is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  1.90  in Relief Therapeutics Holding on September 3, 2024 and sell it today you would earn a total of  311.10  from holding Relief Therapeutics Holding or generate 16373.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy8.69%
ValuesDaily Returns

Spire Global  vs.  Relief Therapeutics Holding

 Performance 
       Timeline  
Spire Global 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Spire Global are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating forward indicators, Spire Global reported solid returns over the last few months and may actually be approaching a breakup point.
Relief Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Relief Therapeutics Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Relief Therapeutics is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Spire Global and Relief Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spire Global and Relief Therapeutics

The main advantage of trading using opposite Spire Global and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spire Global position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.
The idea behind Spire Global and Relief Therapeutics Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios